全部

1·Can the Identification and Treatment of Vulnerable Plaque Benefit Cardiac Prevention?

识别和治疗易损斑块是否能够减少心血管事件？

2·This article reviews the new development of the plasma biomarkers of the vulnerable plaque.

作者对目前研究较多的识别易损斑块的血清生化标志物做一综述。

3·But that does not mean that it translates to a clinical technique for detecting vulnerable plaque.

但这并不意味着就可以应用于临床监测易损伤斑块。

4·Objective: To study the relation between metabolic syndrome(MS)and vulnerable plaque in coronary artery.

目的：探讨代谢综合征（MS）与冠状动脉斑块易损性的关系。

5·Under the influence of intrinsic and extrinsic mediators, vulnerable plaque may develop to rupture, erosion or calcification.

在内外因素的共同作用下，不稳定斑块可能发生破裂、糜烂以及钙化等现象。

6·Pregnancy associated plasma protein-A (PAPP-A) is high molecular weight metalloproteinase and a novel marker of vulnerable plaque.

妊娠相关蛋白- A是一种高分子量的锌结合金属蛋白酶，是易损斑块新的标志物。

7·So, some scholar propose that CD163/HO-1 pathway is hopeful to play a critical role in atherosclerotic vulnerable plaque stabilization.

因此有学者提出，CD163/HO-1通路作为一个新的抗炎途径，有望在稳定动脉粥样硬化不稳定斑块中起着重要作用。

8·Atherosclerotic vulnerable plaque is considered as an important pathologic basis of acute coronary syndrome and sudden cardiac ischemic death.

动脉粥样硬化易损斑块是急性冠脉综合征和心脏缺血性猝死的重要病理基础。

9·Is it compared with the non contrast enhanced intravascular imaging or compared to the other currently available technology to detect the vulnerable plaque?

它比较倾向非对比增强血管内成像，还是其他目前可行的探测易损伤斑块的技术呢？

10·PAPP-A assay is now widely available and several authors have demonstrated its accuracy in detecting vulnerable plaque, and it can predict prognosis and guide therapy.

PAPP - A检测方便，许多研究者已经证明它在检测易损斑块方面的准确性，并且能够预测预后和指导治疗。